<DOC>
	<DOCNO>NCT01186406</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness Gliadel wafer time surgery , follow combination radiation , Temodar , Avastin , combination Avastin Temodar , radiation complete , malignant brain tumor . About six week surgery , subject begin standard radiation therapy , fix dose Avastin every 2 week , daily Temodar six half week radiation . Beginning 2-3 week last radiation therapy , subject give fix dose Avastin intravenously ( vein ) every 14 day . They also give high dose oral Temodar take daily first 5 day 28-day study cycle .</brief_summary>
	<brief_title>Gliadel , XRT , Temodar , Avastin Followed Avastin , Temodar Newly Diagnosed Glioblastoma Multiforme ( GBM )</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Gliosarcoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Patients must MRI consistent WHO grade IV primary malignant glioma ( glioblastoma multiforme gliosarcoma ) , candidate surgical resection Gliadel wafer placement . Patients within 6 week last major surgical procedure . Age ≥ 18 year Candidates Gliadel If prior procedure do , interval least 2 week &gt; 8 week prior major surgical procedure study enrollment No prior radiotherapy chemotherapy brain tumor Karnofsky &gt; 60 % Hemoglobin ≥ 9.0 g/dl , ANC ≥ 1,500 cells/microliters , platelet ≥ 125,000 cells/microliters Serum creatinine ≤ 1.5 mg/dl , serum SGOT bilirubin ≤ 1.5 time upper limit normal . Signed informed consent approve Institutional Review Board If sexually active , patient must agree use appropriate contraceptive measure duration study 6 month afterwards state informed consent . Pregnancy breast feed . Comedication may interfere study result ; e.g . immunosuppressive agent corticosteroid . Active infection require IV antibiotic . Prior treatment radiotherapy chemotherapy brain tumor , irrespective grade tumor . Evidence &gt; grade 1 CNS hemorrhage baseline MRI CT scan . Prior treatment Avastin condition Prior , unrelated malignancy require active treatment exception cervical carcinoma situ adequately treat basal cell squamous cell carcinoma skin AvastinSpecific Inadequately control hypertension ( define systolic blood pressure &gt; 150 and/or diastolic blood pressure &gt; 100 mmHg ) Prior history hypertensive crisis hypertensive encephalopathy New York Heart Association ( NYHA ) Grade II great congestive heart failure History myocardial infarction unstable angina within 6 month prior study enrollment History stroke transient ischemic attack within 6 month prior study enrollment Significant vascular disease ( e.g. , aortic aneurysm , require surgical repair recent peripheral arterial thrombosis ) within 6 month prior study enrollment History hemoptysis ( ≥ ½ teaspoon bright red blood per episode ) within 1 month prior study enrollment Evidence bleed diathesis coagulopathy ( absence therapeutic anticoagulation ) Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior first Avastin infusion anticipation need major surgical procedure course study Core biopsy minor surgical procedure , exclude placement vascular access device , within 7 day prior study enrollment History abdominal fistula , gastrointestinal perforation within 6 month prior study enrollment Serious , nonhealing wound , active ulcer , untreated bone fracture Proteinuria screening demonstrate urine dipstick proteinuria ≥ 2+ ( patient discover ≥2+ proteinuria dipstick urinalysis baseline undergo 24hour urine collection must demonstrate ≤ 1g protein 24 hour eligible ) . Known hypersensitivity component Avastin Pregnant ( positive pregnancy test ) lactation . Use effective mean contraception ( men woman ) subject childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>glioblastoma multiforme</keyword>
	<keyword>gliosarcoma</keyword>
	<keyword>malignant glioma</keyword>
	<keyword>glioma</keyword>
	<keyword>Gliadel</keyword>
	<keyword>carmustine wafer</keyword>
	<keyword>Avastin</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>Temodar</keyword>
	<keyword>temozolomide</keyword>
	<keyword>Pro00025180</keyword>
	<keyword>Desjardins</keyword>
	<keyword>Duke</keyword>
	<keyword>Preston Robert Tisch Brain Tumor Center</keyword>
</DOC>